John Alam is the founder of EIP Pharma. Latest round: Series B. Backed by Access Industries. Based in Cambridge, United States.
John Alam is the CEO of EIP Pharma, a private, clinical-stage therapeutics company focused on CNS disorders. The company, launched in 2014, specializes in developing treatments for diseases like Alzheimer's. EIP Pharma secured a $20.5 million Series B financing round in 2018, led by Access Industries, following a Series A financing in 2017.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide